Bisdemethoxycurcumin induces apoptosis in Activated Hepatic Stellate Cells via cannabinoid receptor 2

Molecules

Volumn 20, Issue 1, 2015, Pages 1277-1292

  Lee, Phil Jun ^a   Woo, Seung Je ^a   Jee, Jun Goo ^b   Sung, Sang Hyun ^c   Kim, Hong Pyo ^a  

^a Ajou University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Adenosine triphosphate (ATP); Bisdemethoxycurcumin (BDMC); Cannabinoid receptor (CBR) 2; Curcumin; Death inducing signaling complex (DISC); Hepatic stellate cells (HSCs); Liver fibrosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIS(4-HYDROXYCINNAMOYL)METHANE; CANNABINOID 2 RECEPTOR; CURCUMIN; PROTEIN;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL LINE; DRUG EFFECTS; FLOW CYTOMETRY; HUMAN; METABOLISM; STELLATE CELL;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; CELL LINE; CURCUMIN; FLOW CYTOMETRY; HEPATIC STELLATE CELLS; HUMANS; PROTEINS; RECEPTOR, CANNABINOID, CB2;

EID: 84921449688     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules20011277     Document Type: Article

References (32)

1. Zhou, W.C.; Zhang, Q.B.; Qiao, L. Pathogenesis of liver cirrhosis. World J. Gastroenterol. 2014, 20, 7312-7324.
2. Efrati, O.; Barak, A.; Modan-Moses, D.; Augarten, A.; Vilozni, D.; Katznelson, D.; Szeinberg, A.; Yahav, J.; Bujanover, Y. Liver cirrhosis and portal hypertension in cystic fibrosis. Eur. J. Gastroenterol. Hepatol. 2003, 15, 1073-1078.
3. Mallat, A.; Teixeira-Clerc, F.; Deveaux, V.; Lotersztajn, S. Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases. Expert Opin. Ther. Targets 2007, 11, 403-409.
4. Lim, M.P.; Devi, L.A.; Rozenfeld, R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis. 2011, 2, e170.
5. Yang, Q.; Liu, H.Y.; Zhang, Y.W.; Wu, W.J.; Tang, W.X. Anandamide induces cell death through lipid rafts in hepatic stellate cells . J. Gastroenterol. Hepatol. 2010, 25, 991-1001.
6. Mahmoud, M.F.; Sewefy, S.E.; Hasan, R.A.; Ibrahim, A. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. Eur. J. Pharmacol. 2014, 742, 118-124.
7. Dewey, W.L. Cannabinoid pharmacology. Pharmacol. Rev. 1986, 38, 151-178.
8. Zhang, Z.; Guo, Y.; Zhang, S.; Zhang, Y.; Wang, Y.; Ni, W.; Kong, D.; Chen, W.; Zheng, S. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro. Eur. J. Pharmacol. 2013, 721, 133-140.
9. Basnet, P.; Skalko-Basnet, N. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011, 16, 4567-4598.
10. Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007, 595, 105-125.
11. Zhang, F.; Zhang, Z.; Chen, L.; Kong, D.; Zhang, X.; Lu, C.; Lu, Y.; Zheng, S. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J. Cell Mol. Med. 2014, 18, 1392-1406.
12. Siegmund, S.V.; Uchinami, H.; Osawa, Y.; Brenner, D.A.; Schwabe, R.F. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 2005, 41, 1085-1095.
13. Julien, B.; Grenard, P.; Teixeira-Clerc, F.; van Nhieu, J.T.; Li, L.; Karsak, M.; Zimmer, A.; Mallat, A.; Lotersztajn, S. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005, 128, a742-a755.
14. Li, Y.B.; Gao, J.L.; Zhong, Z.F.; Hoi, P.M.; Lee, S.M.; Wang, Y.T. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways . Pharmacol. Rep. 2013, 65, 700-709.
15. Kim, H.P.; Wang, X.; Galbiati, F.; Ryter, S.W.; Choi, A.M. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 2004, 18, 1080-1089.
16. Xu, M.X.; Zhao, L.; Deng, C.; Yang, L.; Wang, Y.; Guo, T.; Li, L.; Lin, J.; Zhang, L. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway. Int. J. Oncol. 2013, 43, 1951-1959.
17. Wang, X.; Wang, Y.; Zhang, J.; Kim, H.P.; Ryter, S.W.; Choi, A.M. FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation. Mol. Cell Biol. 2005, 25, 4742-4751.
18. Fernández-Rojo, M.A.; Gongora, M.; Fitzsimmons, R.L.; Martel, N.; Martin, S.D.; Nixon, S.J.; Brooks, A.J.; Ikonomopoulou, M.P.; Martin, S.; Lo, H.P.; et al. Caveolin-1 is necessary for hepatic oxidative lipid metabolism: Evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Rep. 2013, 4, 238-247.
19. Lin, Y.L.; Lin, C.Y.; Chi, C.W.; Huang, Y.T. Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother. Res. 2009, 23, 927-932.
20. Bari, M.; Oddi, S.; de Simone, C.; Spagnolo, P.; Gasperi, V.; Battista, N.; Centonze, D.; Maccarrone, M. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology 2008, 54, 45-50.
21. Lee, P.J.; Shin, I.; Seo, S.Y.; Kim, H.; Kim, H.P. Upregulation of both heme oxygenase-1 and ATPase inhibitory factor 1 renders tumoricidal activity by synthetic flavonoids via depleting cellular ATP. Bioorganic Med. Chem. Lett. 2014, 24, 4845-4849.
22. Kim, H.P. Lightening up Light Therapy. Activation of Retrograde Signaling Pathway by Photobiomodulation. Biomol. Ther. 2014, 22, 491-496.
23. Gressner, O.A.; Weiskirchen, R.; Gressner, A.M. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp. Hepatol . 2007, 6, 7.
24. Li, D.; Friedman, S.L. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy. J. Gastroenterol. Hepatol. 1999, 14, 618-633.
25. Wright, M.C.; Issa, R.; Smart, D.E.; Trim, N.; Murray, G.I.; Primrose, J.N.; Arthur, M.J.; Iredale, J.P.; Mann, D.A. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001, 121, 685-698.
26. Chung, H.T.; Ryter, S.W.; Kim, H.P. Heme oxygenase-1 as a novel metabolic player. Oxid. Med. Cell Longev. 2013, 2013, 814058.
27. Kim, H.P.; Wang, X.; Chen, Z.H.; Lee, S.J.; Huang, M.H.; Wang, Y.; Ryter, S.W.; Choi, A.M. Autophagic proteins regulate cigarette smoke-induced apoptosis: Protective role of heme oxygenase-1. Autophagy 2008, 4, 887-895.
28. Ihrke, G.; Neufeld, E.B.; Meads, T.; Shanks, M.R.; Cassio, D.; Laurent, M.; Schroer, T.A.; Pagano, R.E.; Hubbard, A.L. WIF-B cells: An in vitro model for studies of hepatocyte polarity. J. Cell Biol. 1993, 123, 1761-1775.
29. Cabezon, E.; Butler, P.J.; Runswick, M.J.; Carbajo, R.J.; Walker, J.E. Homologous and heterologous inhibitory effects of ATPase inhibitor proteins on F-ATPases. J. Biol. Chem. 2002, 277, 41334-41341.
30. Tait, S.W.; Green, D.R. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11, 621-632.
31. Zhang, M.; Lee, S.J.; An, C.; Xu, J.F.; Joshi, B.; Nabi, I.R.; Choi, A.M.; Jin, Y. Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis. Free Radic. Biol. Med. 2011, 50, 1252-1262.
32. McFarland, M.J.; Porter, A.C.; Rakhshan, F.R.; Rawat, D.S.; Gibbs, R.A.; Barker, E.L. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J. Biol. Chem. 2004, 279, 41991-41997.